DIS vs DMAC · P/E 16, rev $94.42B vs $157.4M cap
Walt Disney Company (DIS) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Walt Disney Company (DIS) is a entertainment company listed on NYSE. It is led by Bob Iger.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported DIS revenue for 2025-09-27 was $94.42B. Net income was $12.40B. DIS currently screens at market cap $175.14B and trailing P/E 16.1.
DMAC does not have a complete income-statement cache yet.
DIS currently screens at market cap $175.14B and trailing P/E 16.1. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the DIS and DMAC stock pages for the full models.
Not investment advice.